Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Patiromer MAA submitted in E.U.

April 25, 2016

Clusterin shows promise as a therapeutic target and biomarker in osteoporosis

April 25, 2016

Classic galactosemia animal model mimics human cerebral ataxia symptoms

April 25, 2016

Repatha becomes available in Japan

April 22, 2016

BioMarin's BMN-250 begins phase I/II trial, awarded European orphan drug designation for MPS IIIB

April 22, 2016

BioMarin updates findings from phase II study of vosoritide in achondroplasia

April 21, 2016

New model of PMM2-CDG recapitulates human disease in mice

April 21, 2016

IVA-337 demonstrates good safety and tolerability in phase IIa diabetes trial

April 19, 2016

Update on the type 2 diabetes drug candidate TT-401

April 19, 2016

FDA issues complete response letter for Mycapssa in acromegaly

April 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026